USE OF MOMETASONE FUROATE AND SALICYLICACID FOR THE PREPARATION OF PHARMACETUTCAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISORDERS AND THE COMPOSITIONS

摘要

A pharmaceutical composition for topical treatment of psoriasis and other hyperkeratotic and/or scaly dermatoses containing mometasone furoate (0,1 %) and salicylic acid (5 %) in a pharmaceutically acceptable vehicle and a method of using the pharmaceutical composition to treat psoriasis and hyperkeratotic scaly dermatoses are disclosed.